Global Med Form 12b-25--10QSB
                                                     UNITED STATES                       OMB APPROVAL
                                           SECURITIES AND EXCHANGE COMMISSION       ------------------------
                                                Washington, D.C. 20549              OMB Number:    3235-0058
                                                                                    Expires: January 31, 2002
                                                                                    Estimated average burden
                                                      FORM 12b-25                   hours per response . 2.50
                                             NOTIFICATION OF LATE FILING                 SEC FILE NUMBER
(Check One):                                                                        -------------------------
 [ ] Form 10-KSB [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR                 CUSIP NUMBER
     For Quarter Ended: June 30, 2001                                              -------------------------

     [ ] Transition Report on Form 10-K
     [ ] Transition Report on Form 20-F
     [ ] Transition Report on Form 11-K
     [ ] Transition Report on Form 10-Q
     [ ] Transition Report on Form N-SAR
     For the Transition Period Ended: _________________________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant

Former name if applicable

12600 West Colfax, Suite C-420
Address of principal executive office (Street and number)

Lakewood, Colorado 80215
City, state and zip code

                         PART II RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

   | (a)  The reasons  described in  reasonable  detail in Part III of this
   |      form  could  not be  eliminated  without  unreasonable  effort or
   |      expense;
[X]| (b)  The subject annual report,  semi-annual report, transition report
   |      on Form 10-K,  20-F,  11-K or Form N-SAR, or portion thereof will
   |      be filed  on or  before  the  15th  calendar  day  following  the
   |      prescribed  due  date;  or  the  subject   quarterly   report  or
   |      transition  report on Form 10-Q, or portion thereof will be filed
   |      on or before the fifth  calendar day following the prescribed due
   |      date; and
   | (c)  The  accountant's  statement  or other  exhibit  required by Rule
   |      12b-25(c) has been attached if applicable.

                                     PART III

     State below in reasonable  detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR
or the  transition  report  portion  thereof  could  not  be  filed  within  the
prescribed time period. (Attach extra sheets if needed.)

          Registrant has encountered delays in completing its Quarterly report
     on Form 10-Q for the quarter ended June 30, 2001 because of the transition
     to new principal accountants and certain negotiations occurring with
     respect to the Company's financing agreements.

                           PART IV--OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

 Michael I. Ruxin                      (303)                      238-2000
   (Name)                          (Area Code)                (Telephone Number)

(2)  Have all other periodic reports required under Section 13 or 15(d) of the
     Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
     of 1940 during the preceding 12 months or for such shorter period that the
     registrant was required to file such report(s) been filed? If answer is no,
     identify report(s).                                         [ ] Yes  [X] No


(3)  Is it anticipated that any significant change in results of operations from
     the corresponding period for the last fiscal year will be reflected by the
     earnings statements to be included in the subject report or portion
     thereof?                                                    [X] Yes  [ ] No

     If so, attach an explanation of the anticipated change, both narratively
     and quantitatively, and, if appropriate, state the reasons why a reasonable
     estimate of the results cannot be made.

          For the three months ended June 30, 2001, Registrant incurred a net
          loss of approximately $768 thousand on revenues of approximately
          $1.531 million. For the three months ended June 30, 2000, registrant
          incurred a net loss of $2.097 million on revenues of $1.059 million.
          The primary reason for the increase in revenues was increased software
          license, maintenance and usage fees. The net loss decreased primarily
          because of an increase in revenues of $472 thousand and a decrease in
          financing costs of $1.040 million when comparing the three months
          ended June 30, 2001 with the comparable prior period.

          For the six months ended June 30, 2001, Registrant incurred a net loss
          of approximately $1.789 million compared to a net loss of $2.761
          million for the six months ended June 30, 2000. For the six months
          ended June 30, 2001 and 2000, Registrant recognized revenues of $2.790
          million and $1.998 million, respectively. The primary reason for the
          decrease in the net loss is the increase in revenues of $792 thousand,
          and a decrease in financing costs of $1.062 million, which were
          partially offset by higher operating expenses of $758 thousand for the
          six months ended June 30, 2001 compared to the similar period in 2000.


                          GLOBAL MED TECHNOLOGIES, INC.
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: August 14, 2001              By /s/ Gary L. Cook
                                     Gary L. Cook
                                     Director, Acting Principal Financial
                                     Officer and Treasurer

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.


Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).